Data from the U.S. Department of Health and Human Services Medicaid Provider Spending database show that Medicaid payments totaled at least $504,327 in Irving in 2024 for services with HCPCS codes directly related to COVID-19.
Medicaid, the state-managed public health insurance program funded jointly by state and federal governments, provides coverage for low-income families and individuals, seniors, children, and people with disabilities. It is among the largest public health programs in the U.S.
Since Medicaid relies on taxpayer funding, fluctuations in local billing levels illustrate how public health care resources are distributed within a community.
Services considered COVID-19–related in this analysis were those billed with HCPCS codes described or classified as “COVID-19” or “coronavirus” in billing or reference data. Therefore, these totals reflect only those services directly labeled as COVID-19–related in billing records and do not account for pandemic care billed under other or more general medical codes.
Houston’s Medicaid payments for COVID-19 care led all Texas cities in 2024, with claims totaling $5,684,946.
In Irving, 11 providers filed Medicaid claims connected to COVID-19 services in 2024. The most frequently billed code, COVID Specific, represented $440,683 of the total.
On average, Medicaid providers in Irving billed $45,848 per provider for COVID-19–related services—higher than the Texas statewide average of $40,722.
During major pandemic years, COVID-19 services drove significant growth in Medicaid spending in Irving.
From 2020 to 2024, Medicaid payments across other claim categories climbed by $86,645,196, an increase of 175.3%.
Looking at the two years before the pandemic, average yearly Medicaid payments in Irving amounted to $28,774,473.
According to the Centers for Medicare & Medicaid Services, total federal and state Medicaid spending stood at about $871.7 billion in fiscal 2023. That figure made up around 18% of national health expenditures, marking a rise from $613.5 billion in 2019, prior to the COVID-19 pandemic.
This nearly 40% growth over several years is primarily attributed to greater enrollment and increased health care utilization during and after the pandemic.
Federal budget actions in the Trump administration included substantial proposals to reduce Medicaid’s federal funding and alter its structure. The “One Big Beautiful Bill Act,” signed into law in 2025, is expected to decrease federal Medicaid spending by over $1 trillion in the coming decade. The law adds policies such as work requirements and higher cost-sharing, which could potentially reduce enrollment and federal funding for some participants. These adjustments would shift more expenses to states and limit projected federal Medicaid growth, even as the program remains vital for tens of millions of U.S. residents.
| Year | COVID-19–Related Payments | COVID-19 Payments % Change (YoY) | Total Medicaid Payments |
|---|---|---|---|
| 2024 | $504,327 | -76.3% | $136,572,122 |
| 2023 | $2,127,957 | -87.1% | $150,023,797 |
| 2022 | $16,452,567 | -50.7% | $163,579,486 |
| 2021 | $33,351,653 | 293.3% | $166,325,272 |
| 2020 | $8,480,993 | N/A | $57,903,592 |
| 2019 | $0 | N/A | $30,368,295 |
| 2018 | $0 | N/A | $27,180,650 |
| HCPCS Code | Description | Medicaid Payments | Claims |
|---|---|---|---|
| 87635 | COVID Specific | $440,250 | 13,310 |
| 87811 | Immunoassay | $60,444 | 1,847 |
| 86769 | Immunoassay | $2,255 | 110 |
| 90480 | COVID-19 Vaccine Administration | $945 | 38 |
| U0002 | COVID Specific | $433 | 16 |
Note: Includes HCPCS codes explicitly labeled for COVID-19 services; totals do not represent all pandemic-related health care spending.
The U.S. Department of Health and Human Services Medicaid Provider Spending database was the source for information in this report. View the data here.










